Cilomilast GlaxoSmithKline - PubMed (original) (raw)

Affiliations

Review

Cilomilast GlaxoSmithKline

William M Brown. Curr Opin Investig Drugs. 2005 May.

Abstract

GlaxoSmithKline is developing cilomilast, a phosphodiesterase 4 inhibitor, for the potential treatment of chronic obstructive pulmonary disease. The compound has been assessed in phase III clinical trials.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances